Tiny molecule could unlock new treatments for leg artery disease
NCT ID NCT04089943
First seen Feb 25, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study looked at a small molecule called microRNA-210 in 230 people with peripheral artery disease (PAD), a condition that causes leg pain and poor blood flow. Researchers measured the molecule's levels in calf muscle samples and tested how far participants could walk. The goal was to understand how microRNA-210 affects cell stress and energy use, which could lead to better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor Scott and White
Temple, Texas, 76508, United States
-
UT Austing Dell Medical School
Austin, Texas, 78712, United States
Conditions
Explore the condition pages connected to this study.